UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

Antiangiogenic Therapy for Cancer: An Update

Pharmacotherapy, 2012-12, Vol.32 (12), p.1095-1111

2012

Volltextzugriff (PDF)

Nilotinib: A second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia

Clinical therapeutics, 2008-11, Vol.30 (11), p.1956-1975

2008

Volltextzugriff (PDF)

Racial and Ethnic Differences in Cardiac Surveillance Evaluation of Patients Treated With Anthracycline-Based Chemotherapy

Journal of the American Heart Association, 2023-05, Vol.12 (10), p.e027981-e027981

2023

Volltextzugriff (PDF)

Implementation of a pharmacogenetic panel‐based test for pharmacotherapy‐based supportive care in an adult oncology clinic

Clinical and translational science, 2024-07, Vol.17 (7), p.e13890-n/a

2024

Volltextzugriff (PDF)

Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence

Clinical science (1979), 2011-04, Vol.120 (8), p.307

2011

Volltextzugriff (PDF)

Research summary of poster presentations at the 2023 Florida cardio-oncology symposium

American heart journal plus, 2024-01, Vol.37, p.100348-100348, Article 100348

2024

Volltextzugriff (PDF)

Newly diagnosed cardiovascular disease in patients treated with immune checkpoint inhibitors: a retrospective analysis of patients at an academic tertiary care center

Cardio-oncology (London, England), 2021-03, Vol.7 (1), p.10-7, Article 10

2021

Volltextzugriff (PDF)

Lactate Dehydrogenase B and Pyruvate Oxidation Pathway Associated With Carfilzomib-Related Cardiotoxicity in Multiple Myeloma Patients: Result of a Multi-Omics Integrative Analysis

Frontiers in cardiovascular medicine, 2021-04, Vol.8, p.645122-645122

2021

Volltextzugriff (PDF)

Evaluating Treatment Options and the Multidisciplinary Care of Ocular Toxicities of MEK Inhibitors

Oncology (Williston Park, N.Y.), 2023-03, Vol.37 (3), p.138-139

2023

Volltextzugriff (PDF)

Lack of adequate pneumococcal vaccination response in chronic lymphocytic leukaemia patients receiving ibrutinib

British journal of haematology, 2018-09, Vol.182 (5), p.712-714

2018

Volltextzugriff (PDF)

Clinical and Cost Comparison Evaluation of Inpatient Versus Outpatient Administration of EPOCH-Containing Regimens in Non-Hodgkin Lymphoma

Journal of pharmacy practice, 2017-08, Vol.30 (4), p.400-405

2017

Volltextzugriff (PDF)

Tyrosine kinase inhibitors in the treatment of systemic mastocytosis

Leukemia research, 2011-09, Vol.35 (9), p.1143-1152

2011

Volltextzugriff (PDF)

Unraveling Racial Disparities in Supportive Care Medication Use among End-of-Life Pancreatic Cancer Patients: Focus on Pain Management and Psychiatric Therapies

Cancer epidemiology, biomarkers & prevention, 2023-12, Vol.32 (12), p.1675

2023

Volltextzugriff (PDF)

Emergence of ocular toxicities associated with novel anticancer therapeutics: What the oncologist needs to know

Cancer treatment reviews, 2022-04, Vol.105, p.102376-102376, Article 102376

2022

Volltextzugriff (PDF)

Romiplostim resistance in secondary failure of platelet recovery

Journal of oncology pharmacy practice, 2013-12, Vol.19 (4), p.369-372

2013

Volltextzugriff (PDF)

Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans

Journal of the National Medical Association, 2023-04, Vol.115 (2), p.164-174

2023

Volltextzugriff (PDF)

Pharmacy Student Performance in a Capstone Course Utilizing the Pharmacists’ Patient Care Process

American journal of pharmaceutical education, 2019-10, Vol.83 (8), p.7357-1831, Article 7357

2019

Volltextzugriff (PDF)

The Importance of Research and Scholarly Activity in Pharmacy Training

Pharmacotherapy, 2016-12, Vol.36 (12), p.e200-e205

2016

Volltextzugriff (PDF)

National Survey on the Effect of Oncology Drug Shortages in Clinical Practice: A Hematology Oncology Pharmacy Association Survey

JCO oncology practice, 2022-08, Vol.18 (8), p.OP2100883-e1296

2022

Volltextzugriff (PDF)

Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo

Oncotarget, 2014-02, Vol.5 (3), p.775-787

2014

Volltextzugriff (PDF)

Emerging Role of Olanzapine for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting

Pharmacotherapy, 2016-02, Vol.36 (2), p.218-229

2016

Volltextzugriff (PDF)

A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma

Future oncology (London, England), 2023-09, Vol.19 (27), p.1841-1853

2023

Volltextzugriff (PDF)

Immune-mediated adverse events following influenza vaccine in cancer patients receiving immune checkpoint inhibitors

Journal of oncology pharmacy practice, 2020-04, Vol.26 (3), p.647-654

2020

Volltextzugriff (PDF)

Atezolizumab plus tivozanib for immunologically cold tumor types: the IMMCO-1 trial

Future oncology (London, England), 2022-11, Vol.18 (34), p.3815-3822

2022

Volltextzugriff (PDF)

Evaluation of romiplostim for the treatment of secondary failure of platelet recovery among allogeneic hematopoietic stem cell transplant patients

Journal of oncology pharmacy practice, 2017-01, Vol.23 (1), p.10-17

2017

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(60)

Publikationsform

Sprache

Englisch
(65)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Antiangiogenic Therapy for Cancer: An Update

Nilotinib: A second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia

Racial and Ethnic Differences in Cardiac Surveillance Evaluation of Patients Treated With Anthracycline-Based Chemotherapy

Implementation of a pharmacogenetic panel‐based test for pharmacotherapy‐based supportive care in an adult oncology clinic

Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence

Research summary of poster presentations at the 2023 Florida cardio-oncology symposium

Newly diagnosed cardiovascular disease in patients treated with immune checkpoint inhibitors: a retrospective analysis of patients at an academic tertiary care center

Lactate Dehydrogenase B and Pyruvate Oxidation Pathway Associated With Carfilzomib-Related Cardiotoxicity in Multiple Myeloma Patients: Result of a Multi-Omics Integrative Analysis

Evaluating Treatment Options and the Multidisciplinary Care of Ocular Toxicities of MEK Inhibitors

Lack of adequate pneumococcal vaccination response in chronic lymphocytic leukaemia patients receiving ibrutinib

Clinical and Cost Comparison Evaluation of Inpatient Versus Outpatient Administration of EPOCH-Containing Regimens in Non-Hodgkin Lymphoma

Tyrosine kinase inhibitors in the treatment of systemic mastocytosis

Unraveling Racial Disparities in Supportive Care Medication Use among End-of-Life Pancreatic Cancer Patients: Focus on Pain Management and Psychiatric Therapies

Emergence of ocular toxicities associated with novel anticancer therapeutics: What the oncologist needs to know

Romiplostim resistance in secondary failure of platelet recovery

Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans

Pharmacy Student Performance in a Capstone Course Utilizing the Pharmacists’ Patient Care Process

The Importance of Research and Scholarly Activity in Pharmacy Training

National Survey on the Effect of Oncology Drug Shortages in Clinical Practice: A Hematology Oncology Pharmacy Association Survey

Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo

Emerging Role of Olanzapine for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting

A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma

Immune-mediated adverse events following influenza vaccine in cancer patients receiving immune checkpoint inhibitors

Atezolizumab plus tivozanib for immunologically cold tumor types: the IMMCO-1 trial

Evaluation of romiplostim for the treatment of secondary failure of platelet recovery among allogeneic hematopoietic stem cell transplant patients

Suchergebnisse filtern